Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Paradigm Biopharmaceuticals Ltd. has announced a change in the director’s securities holdings, with Paul Rennie disposing of 197,355 fully paid ordinary shares. Despite this reduction, Rennie continues to hold a significant number of shares across various accounts. This move could attract attention from investors watching director trading activities in the company.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
